It may be interesting to note.....the first 5 patients in the study reportedly had their valves implanted in the week of November 14 2021.
The 12 month official followup report (as part of the study protocol) should be soon (as soon as 6 weeks potentially - or not too long after that)...Maybe an early christmas present.
- Forums
- ASX - By Stock
- FDA submission for early feasibility study
AVR
anteris technologies global corp.
Add to My Watchlist
3.43%
!
$5.91

It may be interesting to note.....the first 5 patients in the...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$5.91 |
Change
-0.210(3.43%) |
Mkt cap ! $91.59M |
Open | High | Low | Value | Volume |
$6.01 | $6.08 | $5.85 | $44.71K | 7.43K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 857 | $5.83 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.08 | 260 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 857 | 5.830 |
1 | 900 | 5.780 |
1 | 1000 | 5.610 |
2 | 3500 | 5.600 |
2 | 3736 | 5.500 |
Price($) | Vol. | No. |
---|---|---|
6.080 | 260 | 1 |
6.180 | 50 | 1 |
6.200 | 1000 | 1 |
6.400 | 130 | 1 |
6.500 | 255 | 1 |
Last trade - 15.51pm 26/06/2025 (20 minute delay) ? |
Featured News
AVR (ASX) Chart |
The Watchlist
PTX
PRESCIENT THERAPEUTICS LIMITED
James McDonnell, CEO
James McDonnell
CEO
Previous Video
Next Video
SPONSORED BY The Market Online